COMPARATIVE EFFICACY OF AZADIRACHTA INDICA ORGANIC EXTRACTS AGAINST METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS CLINICAL ISOLATES

Main Article Content

Munazza Zaka Bhatti
Zeeshan Nawaz
Muhammad Asif Zahoor

Keywords

Azadirachta indica, Methicillin-resistant Staphylococcus aureus (MRSA), , Minimum inhibitory concentration (MIC), Thermostable nuclease, Vancomycin

Abstract

The current study targeted the isolation and molecular identification of methicillin-resistant Staphylococcus aureus (MRSA) from various clinical samples (n=100). The samples were processed for bacterial isolation based on cultural, morphological and biochemical profiles followed by amplification of nuc gene encoding for thermostable nuclease of S. aureus. The isolates were screened phenotypically for methicillin resistance using cefoxitin or oxacillin discs and the genomic DNA of each isolate was screened for mec-A gene. Minimum inhibitory concentration (MIC) of vancomycin was also determined for each MRSA isolate. Organic extracts of Azadirachta indica leaves were prepared using ethanol, methanol and chloroform solvents followed by determination of in vitro activity of each extract against the MRSA isolates. A total of 47 isolates were identified as Staphylococci based on cultural, morphological and biochemical profiles, whereas 41 isolates were confirmed as S. aureus based on nuc gene. Phenotypically 13/41 isolates showed resistance to cefoxitin or oxacillin discs and 13/13 isolates were found positive for mec-A gene, hence termed as MRSA. All the isolates were sensitive to vancomycin and showed MIC (0.5-2µg/ml). The mean zone of inhibition was measured as 15.38±1.39 mm and 15.92±1.71 mm for ethanolic and methanolic extracts at 40% concentration, respectively. Whereas the highest zone was measured as 18.38±1.71 mm for chloroform extract at 60% concentration. Altogether, the results indicated that MRSA isolates pose a significant public health threat. However, organic extracts showed significant activity against MRSA isolates along with vancomycin as potential antimicrobial drug.


 


 

Abstract 178 | pdf Downloads 72

References

Akinduti, P. A., V. Emoh-Robinson, H. F. Obamoh-Triumphant, Y. D. Obafemi, and T. T. Banjo. 2022. Antibacterial activities of plant leaf extracts against multi-antibiotic resistant Staphylococcus aureus associated with skin and soft tissue infections. BMC Complement Med Ther 22 (1):47.
Altayb, H. N., N. F. Yassin, S. Hosawi, and I. Kazmi. 2022. In-vitro and in-silico antibacterial activity of Azadirachta indica (Neem), methanolic extract, and identification of Beta.d-Mannofuranoside as a promising antibacterial agent. BMC Plant Biol 22 (1):262.
Anwar, J., M. A. Zahoor, M. K. Zahoor, A. B. Siddique, Z. Nawaz, M. H. Rasool, M. U. Qamar, M. Waseem, S. Z. Hussain, and A. Yasmin. 2018. Efficacy of Azadirachta indica organic extracts against clinical methicillin resistant Staphylococcus aureus isolates. Pak J Pharm Sci 31 (4(Supplementary)):1485-1488.
Asadpour, L., and N. Ghazanfari. 2019. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran. Int Microbiol 22 (4):411-417.
Ashraf, S., U. Chaudhry, A. Raza, D. Ghosh, and X. Zhao. 2018. In vitro activity of ivermectin against Staphylococcus aureus clinical isolates. Antimicrob Resist Infect Control 7:27.
Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 30 (7):1654-60.
Cardoso Guimarães, L., B. Marques de Souza, C. de Oliveira Whitaker, F. Abreu, R. Barreto Rocha Ferreira, and K. R. N. Dos Santos. 2021. Increased biofilm formation by Staphylococcus aureus clinical isolates on surfaces covered with plasma proteins. J Med Microbiol 70 (8).
Gawai, A. A., A. R. Kharat, S. S. Chorge, and S. A. Dhawale. 2023. Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. J Mol Recognit 36 (10):e3051.
Hanif, E., and S. A. Hassan. 2019. Evaluation of antibiotic resistance pattern in clinical isolates of Staphylococcus aureus. Pak J Pharm Sci 32 (3 (Supplementary)):1219-1223.
Idrees, M. M., K. Saeed, M. A. Shahid, M. Akhtar, K. Qammar, J. Hassan, T. Khaliq, and A. Saeed. 2023. Prevalence of mecA- and mecC-Associated Methicillin-Resistant Staphylococcus aureus in Clinical Specimens, Punjab, Pakistan. Biomedicines 11 (3).
Indrawattana, N., O. Sungkhachat, N. Sookrung, M. Chongsa-nguan, A. Tungtrongchitr, S. P. Voravuthikunchai, T. Kong-ngoen, H. Kurazono, and W. Chaicumpa. 2013. Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm. Biomed Res Int 2013:314654.
Kaseke, T. B., Z. Chikwambi, C. Gomo, A. B. Mashingaidze, and C. Murungweni. 2023. Antibacterial activity of medicinal plants on the management of mastitis in dairy cows: A systematic review. Vet Med Sci 9 (6):2800-2819.
McGuinness, W. A., N. Malachowa, and F. R. DeLeo. 2017. Vancomycin Resistance in Staphylococcus aureus
Yale J Biol Med 90 (2):269-281.
Naeem, S., A. B. Siddique, M. K. Zahoor, S. Muzammil, Z. Nawaz, M. Waseem, A. Yasmin, and M. Asif Zahoor. 2021. In vitro efficacy of Azadirachta indica leaf extract against methicillin resistant Staphylococci isolated from skin infection. Pak J Pharm Sci 34 (6(Supplementary)):2303-2308.
Schaumburg, F., M. Pauly, G. Schubert, A. Shittu, S. Tong, F. Leendertz, G. Peters, and K. Becker. 2014. Characterization of a novel thermostable nuclease homolog (NucM) in a highly divergent Staphylococcus aureus clade. J Clin Microbiol 52 (11):4036-8.
Sharma, B., D. Upadhyaya, P. Deshmukh, S. Chakraborty, K. Sahu, S. Satapathy, and S. K. Majumder. 2024. Azadirachta indica (AI)leaf extract coated ZnO-AInanocore-shell particles for enhanced antibacterial activity against methicillin-resistantStaphylococcus aureus(MRSA). Biomed Mater 19 (2).
Singaravelu, S., J. Sankarapillai, A. Sasidharn Chandrakumari, and P. Sinha. 2019. Effect of Azadirachta indica Crude Bark Extracts Concentrations against Gram-Positive and Gram-Negative Bacterial Pathogens. J Pharm Bioallied Sci 11 (1):33-37.
Tahir, R., H. B. Albargi, A. Ahmad, M. B. Qadir, Z. Khaliq, A. Nazir, T. Khalid, M. Batool, S. N. Arshad, M. Jalalah, S. A. Alsareii, and F. A. Harraz. 2023. Development of Sustainable Hydrophilic Azadirachta indica Loaded PVA Nanomembranes for Cosmetic Facemask Applications. Membranes (Basel) 13 (2).
Tan, S., C. Wan, H. Wang, W. Zhou, and M. Shu. 2019. Relationship between nasal Carrier isolates and clinical isolates in children with Staphylococcus aureus infections. Microb Pathog 127:233-238.
Tsuji, S., K. Gotoh, T. Manabe, K. Iio, S. Fukushima, O. Matsushita, and H. Hagiya. 2024. Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates. Diagn Microbiol Infect Dis 110 (1):116399.

Most read articles by the same author(s)